How do I install the Icsm Avoid Tt For Weight Loss skill?

Run npx skillmds@latest add dromlakhani/icsm-avoid-tt-for-weight-loss in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Icsm Avoid Tt For Weight Loss safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: makes network calls. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Icsm Avoid Tt For Weight Loss?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Icsm Avoid Tt For Weight Loss free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Icsm Avoid Tt For Weight Loss?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Icsm Avoid Tt For Weight Loss by dromlakhani

Name: Icsm Avoid Tt For Weight Loss
Rating: 4.5 (4 reviews)
Author: dromlakhani

Icsm Avoid Tt For Weight Loss

The skill advises against using testosterone therapy alone for weight loss or cardio-metabolic improvement. It triggers when a clinician considers prescribing testosterone for obesity or diabetes and questions whether testosterone alone will aid weight loss or improve metabolic parameters.

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Avoid testosterone therapy alone for weight loss or cardio-metabolic improvement

STEP 1 — Gather Information

Collect morning fasting total testosterone (tT), symptoms of hypogonadism (low libido, fatigue, erectile dysfunction), weight/BMI, waist circumference, HbA1c, fasting glucose, lipid profile, and presence of diabetes or metabolic syndrome.

STEP 2 — Rule In / Rule Out

Is hypogonadism confirmed (tT <12 nmol/L plus ≥1 hypogonadal symptom)? If no, rule out testosterone therapy; if yes, proceed.

STEP 3 — Classify or Stratify

Is the primary clinical goal weight loss or cardio‑metabolic improvement (rather than sexual dysfunction, fatigue, or other hypogonadal symptoms)? If yes, classify as “weight‑loss/metabolic goal”; if no, classify as “symptom‑directed goal”.

STEP 4 — Decide

For weight‑loss/metabolic goal: avoid testosterone monotherapy; recommend intensive lifestyle intervention, consider GLP‑1RA or other glucose‑lowering agents, and reassess after 3 months. For symptom‑directed goal: testosterone therapy may be considered to alleviate hypogonadal symptoms, not for weight loss.

Clinical Guardrails / Mimics / Pitfalls

Do not prescribe testosterone solely for weight loss or HbA1c improvement; do not ignore lifestyle modification; avoid testosterone in eugonadal men; monitor hematocrit and polycythemia; do not use testosterone as a substitute for proven metabolic therapies.

Concrete Clinical Example

A 55‑year‑old man with BMI 34, HbA1c 7.2%, tT 9 nmol/L, low libido and fatigue asks if testosterone will help him lose weight. He meets criteria for hypogonadism but his primary request is weight loss. The skill advises against testosterone monotherapy; instead, prescribe intensive lifestyle changes, consider a GLP‑1RA, and re‑evaluate symptoms after 3 months before considering testosterone for symptom relief.

Source: Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024), International Society for Sexual Medicine, 2025, https://doi.org/10.1093/sxmrev/qeaf036

---name: icsm-avoid-tt-for-weight-lossdescription: The skill advises against using testosterone therapy alone for weight loss or cardio-metabolic improvement. It triggers when a clinician considers prescribing testosterone for obesity or diabetes and questions whether testosterone alone will aid weight loss or improve metabolic parameters.---# Avoid testosterone therapy alone for weight loss or cardio-metabolic improvement## STEP 1 — Gather InformationCollect morning fasting total testosterone (tT), symptoms of hypogonadism (low libido, fatigue, erectile dysfunction), weight/BMI, waist circumference, HbA1c, fasting glucose, lipid profile, and presence of diabetes or metabolic syndrome.## STEP 2 — Rule In / Rule OutIs hypogonadism confirmed (tT <12 nmol/L plus ≥1 hypogonadal symptom)? If no, rule out testosterone therapy; if yes, proceed.## STEP 3 — Classify or StratifyIs the primary clinical goal weight loss or cardio‑metabolic improvement (rather than sexual dysfunction, fatigue, or other hypogonadal symptoms)? If yes, classify as “weight‑loss/metabolic goal”; if no, classify as “symptom‑directed goal”.## STEP 4 — DecideFor weight‑loss/metabolic goal: avoid testosterone monotherapy; recommend intensive lifestyle intervention, consider GLP‑1RA or other glucose‑lowering agents, and reassess after 3 months. For symptom‑directed goal: testosterone therapy may be considered to alleviate hypogonadal symptoms, not for weight loss.## Clinical Guardrails / Mimics / PitfallsDo not prescribe testosterone solely for weight loss or HbA1c improvement; do not ignore lifestyle modification; avoid testosterone in eugonadal men; monitor hematocrit and polycythemia; do not use testosterone as a substitute for proven metabolic therapies.## Concrete Clinical ExampleA 55‑year‑old man with BMI 34, HbA1c 7.2%, tT 9 nmol/L, low libido and fatigue asks if testosterone will help him lose weight. He meets criteria for hypogonadism but his primary request is weight loss. The skill advises against testosterone monotherapy; instead, prescribe intensive lifestyle changes, consider a GLP‑1RA, and re‑evaluate symptoms after 3 months before considering testosterone for symptom relief.**Source:** Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024), International Society for Sexual Medicine, 2025, https://doi.org/10.1093/sxmrev/qeaf036

Frequently asked questions